Post-operative arterial thrombosis with non-vitamin K antagonist oral anticoagulants after total hip or knee arthroplasty

作者：Squizzato Alessandro^*; Lussana Federico; Cattaneo Marco

来源：Thrombosis and Haemostasis, 2015, 114(2): 237-244.

DOI：10.1160/TH15-01-0073

• Oral anticoagulant
• myocardial infarction
• stroke
• total hip arthroplasty
• total knee arthroplasty

The incidence of post-operative arterial thrombosis (AT) (acute myocardial infarction [AMI] and ischaemic stroke) is increased in patients undergoing total hip replacement (THR) or total knee replacement (TKR). We compared the incidence of post-operative AT in non-vitamin K antagonist oral anticoagulants (NOACs)-treated and enoxaparin-treated patients, performing a systematic review of phase III randomised controlled trials (RCTs) of venous thromboembolism (VIE) prophylaxis in THR and TKR. Studies were identified by electronic search of MEDLINE and EMBASE database until July 2014. Differences between NOACs and enoxaparin groups in the efficacy and safety outcomes were expressed as odds ratios (ORs) with pertinent 95% confidence intervals (95% Cl). Statistical heterogeneity was assessed with the 12 statistic. Eleven phase III RCTs for a total of 31,319 patients were included. Patients underwent TKR in six studies and THR in five studies. The NOACs under study were dabigatran (four studies), apixaban (three studies) and rivaroxaban (four studies). AT occurred in 0.23% of patients on NOACs and in 0.27% of patients on enoxaparin: the OR at fixed-effect model was 0.86 (95% Cl 0.53-1.40; I-2 11 %). No differences in AT incidence among the three NOACs were observed. The incidence of major and clinically relevant bleeding was similar in NOACs and enoxaparin groups (OR 1.03, 95% CI 0.92-1.15; I-2 38%). In conclusion, in RCTs of pharmacological VTE prophylaxis in patients undergoing THR or TKR, there was no difference in the incidence of post-operative AT among patients treated with NOACs, compared to those treated with enoxaparin.

• 出版日期2015-8